Literature DB >> 21359751

Cultures of proliferating vascular smooth muscle cells from adult human aorta.

H L Kirschenlohr1, J C Metcalfe, D J Grainger.   

Abstract

Abnormal proliferation of human vascular smooth muscle cells (hVSMCs) is a central event in the development of atherosclerosis (1-3) As a result, there is considerable interest in the establishment of hVSMC cultures as a mode1 of this disease process However, it has been noted in the past (4,5) that hVSMCs, especially when cultured by the enzyme-dispersal technique (hVSMC,(ED)), grow poorly in culture compared to VSMCs from other species (e.g., rat) This has limited their use for cell-culture studies. We have recently reported that the reduced proliferative capacity of hVSMC(ED) from adult aorta can be attributed to the endogenous production of active TGF-β(6,7). We (6-8) and others (9-11) have shown that TGF-β; is a potent inhibtior of smooth muscle cell proliferation. Moreover, recent studies in animal models of atherosclerosis (12) have suggested that TGF-P plays a pivotal role in regulation of vessel wall architecture (13). We have also shown that hVSMCs derived by the alternative method of explanting (hVSMC(EX)) have a greater proliferative capacity than the hVSMC(ED) (14) In accordance with our hypotheses, the cells grown from explanted tissue did not produce TGF-β; (14).

Entities:  

Year:  1996        PMID: 21359751     DOI: 10.1385/0-89603-335-X:319

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  2 in total

1.  Phenotypic and Functional Changes of Endothelial and Smooth Muscle Cells in Thoracic Aortic Aneurysms.

Authors:  Anna Malashicheva; Daria Kostina; Aleksandra Kostina; Olga Irtyuga; Irina Voronkina; Larisa Smagina; Elena Ignatieva; Natalia Gavriliuk; Vladimir Uspensky; Olga Moiseeva; Jarle Vaage; Anna Kostareva
Journal:  Int J Vasc Med       Date:  2016-01-19

2.  Aortic Graft at Coronary Artery Bypass Surgery as a Source of Human Aortic Smooth Muscle Cells.

Authors:  Daria Kostina; Dmitry Zverev; Vadim Grebennik; Mikhail Gordeev; Elena Ignatieva; Irina Voronkina; Anna Kostareva; Anna Malashicheva
Journal:  Cell Transplant       Date:  2017-10       Impact factor: 4.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.